2023. Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations . The Review of Diabetic Studies . 6, 2 (Aug. 2023).